-
Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An International Open-Label, Randomised Controlled Trial
Quenby, S., Booth, K., Hiller, L., Coomarasamy, A., de Jong, P. G., Hamulyák, E. N., Scheres, L. J., van Haaps, T. F., Ewington, L., Tewary, S., Goddijn, M. & Middeldorp, S., 1 Jan 2024, In: Obstetrical and Gynecological Survey. 79, 1, p. 6-8 3 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An International Open-Label, Randomized Controlled Trial
Quenby, S., Booth, K., Hiller, L., Coomarasamy, A., de Jong, P. G., Hamulyák, E. N., Scheres, L. J., van Haaps, T. F., Ewington, L., Tewary, S., Goddijn, M. & Middeldorp, S., 1 Oct 2023, In: Obstetrical and Gynecological Survey. 78, 10, p. 586-587 2 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial
ALIFE2 Block Writing Committee & ALIFE2 Investigators, 1 Jul 2023, In: The Lancet. 402, 10395, p. 54-61 8 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications